Abstract
Photodynamic therapy (PDT) uses photosensitizer (PS) to generate reactive oxygen species (ROS) under light to trigger cell apoptosis in cancer treatment. Organelle-targeted PS can effectively enhance the efficacy of phototherapy by specifically destroying subcellular organelles. The cell membrane, as an important organelle, is the “protective wall” of cells maintaining the integrity and normal life activities of cells. The damage to cell membranes is fatal to cells. However, utilizing functional PS to achieve cell membrane-targeted PDT, and realize real-time and accurate in situ reporting of cell membrane damage and monitoring of the treatment process, are challenging tasks. In this work, we prepared a photosensitizer (2TPAO) with aggregation-induced emission (AIE) characteristics, good water solubility, strong near-infrared fluorescence, and the capability for specific imaging of cell membranes. Moreover, 2TPAO could effectively produce ROS under visible light irradiation and achieve photodynamic ablation of tumor cells and tumors. Meanwhile, during PDT, the fluorescence changes of 2TPAO indicated the destruction of cell membranes, allowing intuitive determination of the phototherapy results. Therefore, 2TPAO is an effective cell membrane-targeted PS for cancer PDT.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call